Anxiety, insomnia, pain relief: There are many reasons Americans increasingly use CBD.
The Food and Drug Administration hasn't formally approved CBD as a treatment for much of anything, though, and it's a no-no for CBD companies to make bold claims in their marketing about what their products are capable of.
That's exactly what Scottsdale-based Cannafyl has been doing, according to the FDA, which recently issued a warning to the company about claims it's been making on its website.
In its marketing, Cannafyl has said its CBD can help "manage cancer growth" and "control cravings for opioids." The company, whose founder and CEO is "serial entrepreneur" Ed Chaney, also suggested its CBD products "might positively affect COVID-19."
"FDA is taking urgent measures to protect consumers from certain products that, without approval or authorization by FDA, claim to mitigate, prevent, treat, diagnose, or cure COVID-19 in people," the FDA wrote to the company in early March. "You sell products that are intended to mitigate, prevent, treat, diagnose, or cure COVID-19 in people. We request that you take immediate action to cease the sale of any unapproved and unauthorized products for the mitigation, prevention, treatment, diagnosis, or cure of COVID-19."
The FDA also took issue with Cannafyl's statements about its CBD pet products, including the claim that its Pet CBD Drops could "help control tumor growths" and "prevent many types of cancer," including lymphoma, osteosarcoma, and melanoma.
Cannafyl did not respond to Phoenix New Times' requests for comment. The company has until this week to notify the FDA of the steps it is taking to address potential violations.
The FDA letter can be read here.
Keep Phoenix New Times Free... Since we started Phoenix New Times, it has been defined as the free, independent voice of Phoenix, and we would like to keep it that way. Offering our readers free access to incisive coverage of local news, food and culture. Producing stories on everything from political scandals to the hottest new bands, with gutsy reporting, stylish writing, and staffers who've won everything from the Society of Professional Journalists' Sigma Delta Chi feature-writing award to the Casey Medal for Meritorious Journalism. But with local journalism's existence under siege and advertising revenue setbacks having a larger impact, it is important now more than ever for us to rally support behind funding our local journalism. You can help by participating in our "I Support" membership program, allowing us to keep covering Phoenix with no paywalls.